Prosecution Insights
Last updated: November 06, 2026

Arya Ahmadi Bazargani, USPTO Patent Examiner

Listed by the USPTO as BAZARGANI, ARYA AHMADI

Tech Center 3700 • Art Units: 1600 1611 1613 1614 1615 1625 3774

This examiner grants 62% of resolved cases

Analysis

BAZARGANI, ARYA AHMADI has 8 resolved cases in Tech Center 3700 and Art Unit 1600. The allowance rate is 62.5%, and the median time to allowance is 951 days. The small resolved docket limits the breadth of the profile, so these figures provide an initial signal rather than an extensive historical pattern.

The interview lift is 31.3%, indicating that interviews are associated with a meaningful change in outcomes in the available cases. The leading companies are The Regents of the University of California, Merck Patent GmbH, and BASF SE. The leading firms are MARSHALL, GERSTEIN & BORUN LLP, ROTHWELL, FIGG, ERNST & MANBECK, P.C., and BakerHostetler.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

62.5%
Allow Rate
-7.5% vs TC avg
52
Total Applications
+31.3%
Interview Lift
951
Avg Prosecution Days
Based on 8 resolved cases, 2023–2026

Rejection Statute Breakdown

3.9%
§101 Eligibility
11.3%
§102 Novelty
44.3%
§103 Obviousness
30.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18769141 TOPICAL ANALGESICS Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17423592 METHOD FOR MANUFACTURING A SOLID ADMINISTRATION FORM AND SOLID ADMINISTRATION Non-Final OA MERCK PATENT GMBH
18681909 AGROCHEMICAL COMPOSITION Non-Final OA BASF SE
18719998 DEVICES CONTAINING PLANT-SUITABLE ACTIVE INGREDIENTS THAT ARE APPLIED TO THE SOIL OR TO THE AERIAL PARTS OF PLANTS Final Rejection COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
18860487 Drug Releasing Hydrogels, Materials, Devices, and Uses Related Thereto Non-Final OA Georgia Tech Research Corporation
17923182 METHODS FOR SYNTHESIZING ANHYDROUS LACTIC ACID Non-Final OA Otsuka Pharmaceutical Co., Ltd.
18715873 CREAMY COSMETIC COMPOSITION Final Rejection SHISEIDO COMPANY, LTD.
18832464 INJECTABLE FORMULATION CONTAINING ISOXAZOLINE DERIVATIVE Non-Final OA LG CHEM, LTD.
18599930 SKIN CARE COMPOSITIONS Non-Final OA Colgate-Palmolive Company
18834306 CONTROLLED DRUG RELEASE PREPARATION COMPOSITION AND CONTROLLED DRUG RELEASE PREPARATION Final Rejection SUMITOMO SEIKA CHEMICALS CO., LTD.
18548690 ORAL THIN FILM Final Rejection LTS LOHMANN THERAPIE-SYSTEME AG
18715607 PARTICLES, AQUEOUS DISPERSIONS, AND LIQUID COMPOSITIONS HAVING HIGH LIPOPHILIC COMPONENT CONCENTRATIONS AND HIGH LIPOPHILIC COMPONENT TO SURFACTANT RATIOS Final Rejection Spoke Sciences, Inc.
18699241 ORGANOSULFUR COMPOUNDS AS PLANT BIOSTIMULANTS Final Rejection Crop Health Vision B.V.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Arya Ahmadi Bazargani's allowance rate?

62.5% of resolved applications examined by Arya Ahmadi Bazargani were allowed (8 resolved cases), compared with 36.7% across Art Unit 1600 over the last five years.

Does an interview help with examiner Arya Ahmadi Bazargani?

This examiner's interview lift is +31.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Arya Ahmadi Bazargani take to allow a patent?

Applications allowed by Arya Ahmadi Bazargani took 951 days on average from filing to allowance.

Which art unit does examiner Arya Ahmadi Bazargani work in?

Arya Ahmadi Bazargani examines applications in Art Unit 1600 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month